These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6148876)

  • 21. Long-term renal vasodilator effect of the beta-adrenoceptor blocker tertatolol in conscious spontaneously hypertensive rats.
    Nievelstein HN; Tyssen CM; Smits JF; Struyker-Boudier HA
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):252-4. PubMed ID: 2459558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
    Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
    Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cyclosporine administration on renal hemodynamics in conscious rats.
    Murray BM; Paller MS; Ferris TF
    Kidney Int; 1985 Nov; 28(5):767-74. PubMed ID: 3910916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bradykinin B2-receptors mediate the pressor and renal hemodynamic effects of intravenous bradykinin in conscious rats.
    Hoagland KM; Maddox DA; Martin DS
    J Auton Nerv Syst; 1999 Jan; 75(1):7-15. PubMed ID: 9935264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial acute effects of selective modulation of renal dopamine system by gamma-L-glutamyl-L-dopa in rabbits with congestive heart failure.
    Wang ZQ; Way D; Shimizu K; Fong F; Trigg L; McGrath BP
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):1004-11. PubMed ID: 7687706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiohemodynamic effects of nipradilol (K-351) in the dog: comparison with propranolol, nadolol and prazosin.
    Kawada M; Satoh K; Taira N
    Jpn J Pharmacol; 1986 Sep; 42(1):9-18. PubMed ID: 2879055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of atenolol and propranolol on systemic and regional hemodynamics].
    Medvedev OS; Iuzhakov SD; Mashkovskiĭ MD; Val'dman AV; Ismailov ShI
    Biull Eksp Biol Med; 1983 Jul; 96(7):59-61. PubMed ID: 6871455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of nadolol and propranolol on plasma lidocaine clearance.
    Schneck DW; Luderer JR; Davis D; Vary J
    Clin Pharmacol Ther; 1984 Nov; 36(5):584-7. PubMed ID: 6488678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the rate of infusion on cyclosporine nephrotoxicity in the rat.
    Finn WF; McCormack AJ; Sullivan BA; Hak LJ; Clark RL
    Ren Fail; 1989; 11(1):3-15. PubMed ID: 2772285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
    Bhatt P; Makwana D; Santani D; Goyal R
    Can J Physiol Pharmacol; 2007 May; 85(5):514-20. PubMed ID: 17632586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of tertatolol and nadolol on systemic and renal hemodynamics in patients with essential hypertension.
    Degaute JP; Naeije R; Abramowicz M; Leeman M; Schoutens A; Prost JF
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):263S-268S. PubMed ID: 3415803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splanchnic organ blood flow during calcitonin gene-related peptide-induced hypotension with or without propranolol in dogs.
    Takeda S; Tomaru T; Inada Y
    Anesth Analg; 2000 Jun; 90(6):1275-80. PubMed ID: 10825307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal hemodynamic effects of tertatolol compared with those of propranolol in the conscious dog.
    Laubie M; Prost JF; Rochat C
    Am J Nephrol; 1986; 6 Suppl 2():20-4. PubMed ID: 2879468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets.
    Chin A; Radhakrishnan J; Fornell L; John E
    J Pediatr Surg; 2001 Dec; 36(12):1824-8. PubMed ID: 11733915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divergent effects of propranolol and nadolol in isolated mesenteric arteries from normal and portal hypertensive rats.
    Stauber RE; Heinemann A; Trauner M; Krejs GJ
    Eur J Clin Invest; 1996 Aug; 26(8):676-80. PubMed ID: 8872063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic changes that accompany the pressor response to propranolol in urethane anesthetized rats subjected to alpha-blockade.
    Abdelrahman A; Pang CC
    Pharmacology; 1990; 40(5):293-300. PubMed ID: 1980368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta blockers and renal function: a reappraisal.
    Epstein M; Oster JR
    J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA; Crawford MH; O'Rourke RA
    Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereospecificity of beta-adrenoceptor blockade and renal vasodilatation by tertatolol.
    Smits JF; Zeegers HH; Struyker-Boudier HA
    Arch Int Pharmacodyn Ther; 1989; 298():164-71. PubMed ID: 2569294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class III action of beta-blocking agents.
    Taggart P; Donaldson R; Abed J; Nashat F
    Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.